Involvement of heat shock proteins and parkin/α-synuclein axis in Parkinson’s disease

被引:0
作者
Nina Aghazadeh
Elmira Aboutalebi Vand Beilankouhi
Farima Fakhri
Morad Kohandel Gargari
Parisa Bahari
Aliasghar Moghadami
Zhila Khodabandeh
Mohammad Valilo
机构
[1] Islamic Azad University,Department of biology
[2] Tabriz University of Medical Sciences,Immunology Research Center
[3] Kerman University of Medical Sciences,Research Institute for Neuroscience
[4] Imamreza Hospital,Faculty of Medicine
[5] Tabriz University of Medical Sciences,Department of Clinical Biochemistry
[6] Zanjan University of Medical Sciences,Department of Clinical Biochemistry and Medical Laboratories, Faculty of Medicine
[7] Tabriz University of Medical Sciences,Department of Biology, Faculty of Science
[8] Urmia University,undefined
来源
Molecular Biology Reports | 2022年 / 49卷
关键词
α-synuclein; Apoptosis; Heat shock proteins; Lewy bodies; Parkinson’s disease; Neurodegenerative disease;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is one of the most common neurological diseases, next only to Alzheimer’s disease (AD) in terms of prevalence. It afflicts about 2–3% of individuals over 65 years old. The etiology of PD is unknown and several environmental and genetic factors are involved. From a pathological point of view, PD is characterized by the loss of dopaminergic neurons in the substantia nigra, which causes the abnormal accumulation of α-synuclein (α-syn) (a component of Lewy bodies), which subsequently interact with heat shock proteins (HSPs), leading to apoptosis. Apoptosis is a vital pathway for establishing homeostasis in body tissues, which is regulated by pro-apoptotic and anti-apoptotic factors. Recent findings have shown that HSPs, especially HSP27 and HSP70, play a pivotal role in regulating apoptosis by influencing the factors involved in the apoptosis pathway. Moreover, it has been reported that the expression of these HSPs in the nervous system is high. Apart from this finding, investigations have suggested that HSP27 and HSP70 (related to parkin) show a potent protective and anti-apoptotic impact against the damaging outcomes of mutant α-syn toxicity to nerve cells. Therefore, in this study, we aimed to investigate the relationship between these HSPs and apoptosis in patients with PD.
引用
收藏
页码:11061 / 11070
页数:9
相关论文
共 144 条
[1]  
Hayes MT(2019)Parkinson’s disease and parkinsonism Am J Med 132 802-807
[2]  
Mota A(2019)Paraoxonase1 and its relationship with Parkinson’s disease Brain 4 1-6
[3]  
Taheraghdam A(2010)Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism J Neurol 257 1170-1175
[4]  
Valilo M(2019)Parkinson’s disease and the environment Front Neurol 10 218-72
[5]  
Guo J-f(2020)Symptom burden among individuals with Parkinson disease: a national survey Neurology: Clin Pract 10 65-74
[6]  
Ball N(2019)Association of Paraoxonse1 (PON1) Genotypes with the Activity of PON1 in Patients with Parkinson’s Disease Acta Neurol Taiwan 28 66-810
[7]  
Tarolli CG(2021)Serum lipid profile of Parkinson’s disease patients: A study from the Northwest of Iran Caspian J Intern Med 12 155-2754
[8]  
Mota A(2019)Targeting α-synuclein in Parkinson’s disease: progress towards the development of disease-modifying therapeutics Drugs 79 797-752
[9]  
Saedi S(2018)Inhibiting stearoyl-CoA desaturase ameliorates α-synuclein cytotoxicity Cell Rep 25 2742-793
[10]  
Savitt D(2020)The role of α-synuclein oligomers in Parkinson’s disease Int J Mol Sci 21 8645-4771